Drug Shortage Report for SUCCINYLCHOLINE CHLORIDE INJECTION USP

Last updated on 2022-04-27 History
Report ID 155681
Drug Identification Number 02422336
Brand name SUCCINYLCHOLINE CHLORIDE INJECTION USP
Common or Proper name SUCCINYLCHOLINE CHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 ML
ATC code M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-02-25
Estimated end date 2022-04-08
Actual end date 2022-04-26
Shortage status Resolved
Updated date 2022-04-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-04-27 French Compare
v5 2022-04-27 English Compare
v4 2022-02-26 English Compare
v3 2022-02-25 French Compare
v2 2022-02-25 English Compare
v1 2022-02-25 English Compare

Showing 1 to 6 of 6